193 related articles for article (PubMed ID: 30412596)
61. The effectiveness and cost-effectiveness of cinacalcet for secondary hyperparathyroidism in end-stage renal disease patients on dialysis: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Mealing S; Roome C; Snaith A; D'Souza R; Welch K; Stein K
Health Technol Assess; 2007 May; 11(18):iii, xi-xiii, 1-167. PubMed ID: 17462168
[TBL] [Abstract][Full Text] [Related]
62. Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study.
Lin E; Chertow GM; Yan B; Malcolm E; Goldhaber-Fiebert JD
PLoS Med; 2018 Mar; 15(3):e1002532. PubMed ID: 29584720
[TBL] [Abstract][Full Text] [Related]
63. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
[TBL] [Abstract][Full Text] [Related]
64. The cost-effectiveness of screening for oral cancer in primary care.
Speight PM; Palmer S; Moles DR; Downer MC; Smith DH; Henriksson M; Augustovski F
Health Technol Assess; 2006 Apr; 10(14):1-144, iii-iv. PubMed ID: 16707071
[TBL] [Abstract][Full Text] [Related]
65. Cost-utility of empagliflozin in patients with type 2 diabetes at high cardiovascular risk.
Nguyen E; Coleman CI; Nair S; Weeda ER
J Diabetes Complications; 2018 Feb; 32(2):210-215. PubMed ID: 29157870
[TBL] [Abstract][Full Text] [Related]
66. Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France.
Druais S; Doutriaux A; Cognet M; Godet A; Lançon C; Levy P; Samalin L; Guillon P
Pharmacoeconomics; 2016 Apr; 34(4):363-91. PubMed ID: 26883132
[TBL] [Abstract][Full Text] [Related]
67. Cost and clinical implications of diabetes prevention in an Australian setting: a long-term modeling analysis.
Palmer AJ; Tucker DM
Prim Care Diabetes; 2012 Jul; 6(2):109-21. PubMed ID: 22153888
[TBL] [Abstract][Full Text] [Related]
68. Cost effectiveness of a pharmacist-led information technology intervention for reducing rates of clinically important errors in medicines management in general practices (PINCER).
Elliott RA; Putman KD; Franklin M; Annemans L; Verhaeghe N; Eden M; Hayre J; Rodgers S; Sheikh A; Avery AJ
Pharmacoeconomics; 2014 Jun; 32(6):573-90. PubMed ID: 24639038
[TBL] [Abstract][Full Text] [Related]
69. Bempedoic acid for high-risk patients with CVD as adjunct lipid-lowering therapy: A cost-effectiveness analysis.
Perera K; Kam N; Ademi Z; Liew D; Zomer E
J Clin Lipidol; 2020; 14(6):772-783. PubMed ID: 32994152
[TBL] [Abstract][Full Text] [Related]
70. Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.
Colquitt JL; Mendes D; Clegg AJ; Harris P; Cooper K; Picot J; Bryant J
Health Technol Assess; 2014 Aug; 18(56):1-560. PubMed ID: 25169727
[TBL] [Abstract][Full Text] [Related]
71. Exploring the cost-effectiveness of EBV vaccination to prevent multiple sclerosis in an Australian setting.
Palmer AJ; Zhao T; Taylor BV; van der Mei I; Campbell JA
J Neurol Neurosurg Psychiatry; 2024 Apr; 95(5):401-409. PubMed ID: 37918903
[TBL] [Abstract][Full Text] [Related]
72. Residual cardiovascular risk reduction guided by lifetime benefit estimation in patients with symptomatic atherosclerotic disease: effectiveness and cost-effectiveness.
Hageman SHJ; Dorresteijn JAN; Bots ML; Asselbergs FW; Westerink J; van der Meulen MP; Mosterd A; Visseren FLJ; ; Asselbergs FW; Nathoe HM; de Borst GJ; Bots ML; Geerlings MI; Emmelot MH; de Jong PA; Leiner T; Lely AT; van der Kaaij NP; Kappelle LJ; Ruigrok YM; Verhaar MC; Visseren FLJ; Westerink J
Eur J Prev Cardiol; 2022 Mar; 29(4):635-644. PubMed ID: 34009323
[TBL] [Abstract][Full Text] [Related]
73. Cost-Effectiveness of Laparoscopic Hysterectomy With Morcellation Compared With Abdominal Hysterectomy for Presumed Myomas.
Rutstein SE; Siedhoff MT; Geller EJ; Doll KM; Wu JM; Clarke-Pearson DL; Wheeler SB
J Minim Invasive Gynecol; 2016 Feb; 23(2):223-33. PubMed ID: 26475764
[TBL] [Abstract][Full Text] [Related]
74. Cost-effectiveness of Evolocumab in Patients With High Cardiovascular Risk in Spain.
Villa G; Lothgren M; Kutikova L; Lindgren P; Gandra SR; Fonarow GC; Sorio F; Masana L; Bayes-Genis A; Hout BV
Clin Ther; 2017 Apr; 39(4):771-786.e3. PubMed ID: 28366593
[TBL] [Abstract][Full Text] [Related]
75. Cost-effectiveness of Canakinumab for Prevention of Recurrent Cardiovascular Events.
Sehested TSG; Bjerre J; Ku S; Chang A; Jahansouz A; Owens DK; Hlatky MA; Goldhaber-Fiebert JD
JAMA Cardiol; 2019 Feb; 4(2):128-135. PubMed ID: 30649147
[TBL] [Abstract][Full Text] [Related]
76. Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fatty liver disease: a Markov model informed by a feasibility study.
Tanajewski L; Harris R; Harman DJ; Aithal GP; Card TR; Gkountouras G; Berdunov V; Guha IN; Elliott RA
BMJ Open; 2017 Jul; 7(6):e015659. PubMed ID: 28679676
[TBL] [Abstract][Full Text] [Related]
77. A standardized vascular disease health check in europe: a cost-effectiveness analysis.
Schuetz CA; Alperin P; Guda S; van Herick A; Cariou B; Eddy D; Gumprecht J; Nicolucci A; Schwarz P; Wareham NJ; Witte DR; Smith U
PLoS One; 2013; 8(7):e66454. PubMed ID: 23869204
[TBL] [Abstract][Full Text] [Related]
78. Cost-effectiveness of habit-based advice for weight control versus usual care in general practice in the Ten Top Tips (10TT) trial: economic evaluation based on a randomised controlled trial.
Patel N; Beeken RJ; Leurent B; Omar RZ; Nazareth I; Morris S
BMJ Open; 2018 Aug; 8(8):e017511. PubMed ID: 30104307
[TBL] [Abstract][Full Text] [Related]
79. Cost-Effectiveness of a Government Policy to Incentivise Chronic Disease Management following Stroke: A Modelling Study.
Orman Z; Cadilhac DA; Andrew NE; Kilkenny MF; Olaiya MT; Thrift AG; Ung D; Dalli LL; Churilov L; Sundararajan V; Lannin NA; Nelson MR; Srikanth V; Kim J
Neuroepidemiology; 2024; 58(3):208-217. PubMed ID: 38290479
[TBL] [Abstract][Full Text] [Related]
80. Cost-Effectiveness of a Psycho-Educational Intervention Targeting Fear of Cancer Recurrence in People Treated for Early-Stage Melanoma.
Dieng M; Khanna N; Kasparian NA; Costa DSJ; Butow PN; Menzies SW; Mann GJ; Cust AE; Morton RL
Appl Health Econ Health Policy; 2019 Oct; 17(5):669-681. PubMed ID: 31228015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
